Exa-Cel Gene Therapy Improves Quality of Life in Severe Sickle Cell Disease

THURSDAY, Sept. 4, 2025 (HealthDay News) -- Exagamglogene autotemcel (exa-cel), a one-time, ex vivo CRISPR-Cas9 gene-edited cell therapy, is beneficial for adul